Scientists test first means, get out the cause and not the effect of heart disease
Over the next five years on the market may appear first vaccines against heart disease. This forecast was announced at the last conference in London at the Royal College of London, reports The Telegraph.
This is an injection that can prevent the accumulation of fat in the arteries, leading to their narrowing and heart attacks. This will be the first-in means the cause, not the consequence. At this point in the development of such vaccines are several.
Professor Nilsson of Lund University says that the modern means such as statin drugs, which lower the pressure, reduce the risk of strokes and heart attacks by 40%. But it was experimentally proved that may change the way the immune system reacts to the deposits in the arteries. As a result, reduce the severity of inflammation and plaque will be less active delayed.
Based on this position, the scientists succeeded in creating a vaccine CardioVax CVX-210 in the form of injectable drug which reduces the deposition of 60-70%. There is also information about the second vaccine, using the same components, but in the form of nasal spray.
Testing takes place and method of direct injection of antibodies that combat LDL underlying sediments. Initial tests antibody BI-204 showed could achieve a reduction of deposits by 50%. The vaccine is safe with antibodies that confirmed the tests on 80 healthy volunteers.